Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
25.81
+0.13 (0.51%)
At close: Mar 24, 2026, 4:00 PM EDT
26.03
+0.22 (0.85%)
Pre-market: Mar 25, 2026, 6:04 AM EDT
Genmab Market Cap
Genmab has a market cap or net worth of $15.7 billion as of March 25, 2026. Its market cap has decreased by -1.71% in one year.
Market Cap
15.70B
Enterprise Value
19.37B
1-Year Change
-1.71%
Ranking
Category
Stock Price
$25.81
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $15.70B, an increase of 3,634.73%. That is a compound annual growth rate of 29.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 16.50B | -16.58% |
| Dec 31, 2025 | 19.78B | 43.19% |
| Dec 31, 2024 | 13.81B | -34.35% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
| Apr 23, 2012 | 420.50M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioNTech SE | 22.22B |
| Moderna | 20.25B |
| Roivant Sciences | 19.99B |
| Royalty Pharma | 19.54B |
| Revolution Medicines | 19.15B |
| Incyte | 18.00B |
| BridgeBio Pharma | 13.49B |
| Ascendis Pharma | 13.38B |